Stealth BioTherapeutics Corp
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$53,769,000 over the previous period. Total operating expenses were $46,303,000.
Profit Margin
| 2016 | 0 | -61.04M | |
|---|---|---|---|
| 2017 | 0 | -82.90M | |
| 2018 | 0 | -96.71M | |
| 2019 | 21.08M | -71.72M | -340.15% |
| 2020 | 0 | -57.45M | |
| 2021 | 0 | -53.76M |
MITO Income Statement (2016 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 21.08M | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 21.08M | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 26.55M | 29.30M | 44.60M | 53.06M | 63.21M | 48.44M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 46.30M | 48.67M | 66.91M | 75.27M | 79.72M | 61.84M |
Operating income | -51.28M | -48.67M | -45.83M | -75.27M | -79.72M | -61.84M |
Other income (expenses), net | -1.24M | -8.78M | -25.89M | -21.43M | -3.18M | 799.02K |
Income before tax | -52.52M | -57.45M | -71.72M | -96.71M | -82.90M | -61.04M |
Income tax expense | 1.24M | -6.97M | -19.23M | -76.21K | 92.3K | 799.02K |
Net income | -53.76M | -57.45M | -71.72M | -96.71M | -82.90M | -61.04M |
Earnings per share | ||||||
Basic EPS | -1.16 | -1.24 | -2.29 | -2.93 | -5.22 | -2.99 |
Diluted EPS | -1.16 | -1.24 | -2.29 | -2.93 | -5.22 | -2.99 |
| Data source | Data source | Data source | Data source |